296 related articles for article (PubMed ID: 21680755)
1. Vascular and metabolic dysfunction in Alzheimer's disease: a review.
Murray IV; Proza JF; Sohrabji F; Lawler JM
Exp Biol Med (Maywood); 2011 Jul; 236(7):772-82. PubMed ID: 21680755
[TBL] [Abstract][Full Text] [Related]
2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology.
Bennett S; Grant MM; Aldred S
J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress and Alzheimer's disease].
Liu XJ; Yang W; Qi JS
Sheng Li Xue Bao; 2012 Feb; 64(1):87-95. PubMed ID: 22348966
[TBL] [Abstract][Full Text] [Related]
8. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
9. Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro.
Coskuner O; Murray IV
J Alzheimers Dis; 2014; 41(2):561-74. PubMed ID: 24625803
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
Hamel E; Nicolakakis N; Aboulkassim T; Ongali B; Tong XK
Exp Physiol; 2008 Jan; 93(1):116-20. PubMed ID: 17911359
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
12. Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress.
Polidori MC; Pientka L
J Alzheimers Dis; 2012; 28(1):1-9. PubMed ID: 22002788
[TBL] [Abstract][Full Text] [Related]
13. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
Watt AD; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
[TBL] [Abstract][Full Text] [Related]
14. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
Van Broeck B; Van Broeckhoven C; Kumar-Singh S
Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
de la Torre JC
Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
[TBL] [Abstract][Full Text] [Related]
16. The imbalance of vascular molecules in Alzheimer's disease.
Bell RD
J Alzheimers Dis; 2012; 32(3):699-709. PubMed ID: 22850315
[TBL] [Abstract][Full Text] [Related]
17. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.
Takechi R; Galloway S; Pallebage-Gamarallage MM; Lam V; Mamo JC
Prog Lipid Res; 2010 Apr; 49(2):159-70. PubMed ID: 19896503
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
20. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
He JT; Zhao X; Xu L; Mao CY
J Alzheimers Dis; 2020; 73(1):39-58. PubMed ID: 31815697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
